Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -75,595 | -113,575 | -291,955 | -276,011 | -239,284 |
| Depreciation Amortization | 8,077 | 7,384 | 2,811 | 1,149 | 776 |
| Accounts receivable | -8,123 | -11,103 | -9,670 | 0 | N/A |
| Accounts payable and accrued liabilities | -1,526 | -7,008 | 7,657 | 2,231 | 2,806 |
| Other Working Capital | 23,283 | -5,142 | 7,939 | 12,543 | -11,073 |
| Other Operating Activity | 76,260 | 105,339 | 110,748 | 118,398 | 92,307 |
| Operating Cash Flow | $22,376 | $-24,105 | $-172,470 | $-141,690 | $-154,468 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -306 | -609 | -431 | -7,284 | -1,181 |
| Purchase Of Investment | -127,198 | -107,502 | -79,729 | -81,794 | -214,806 |
| Sale Of Investment | 132,667 | 50,488 | 114,724 | 231,267 | 133,222 |
| Purchase Sale Intangibles | N/A | N/A | -50,000 | 0 | N/A |
| Other Investing Activity | 0 | 0 | -50,000 | 0 | -3,098 |
| Investing Cash Flow | $5,163 | $-57,623 | $-15,436 | $142,189 | $-85,863 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | 105,000 | 50,000 | 0 | N/A |
| Debt Repayment | -80,000 | N/A | 0 | N/A | N/A |
| Common Stock Issued | 1,351 | 7,652 | 26,685 | 162,430 | 233,361 |
| Other Financing Activity | -13,418 | -4,201 | -1,575 | 0 | 0 |
| Financing Cash Flow | $-67,067 | $108,451 | $75,110 | $162,430 | $233,361 |
| Beginning Cash Position | 112,738 | 86,015 | 198,811 | 35,882 | 38,539 |
| End Cash Position | 73,210 | 112,738 | 86,015 | 198,811 | 31,569 |
| Net Cash Flow | $-39,528 | $26,723 | $-112,796 | $162,929 | $-6,970 |
| Free Cash Flow | |||||
| Operating Cash Flow | 22,376 | -24,105 | -172,470 | -141,690 | -154,468 |
| Capital Expenditure | -306 | -609 | -431 | -7,284 | -1,181 |
| Free Cash Flow | 22,070 | -24,714 | -172,901 | -148,974 | -155,649 |